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To explore the relationship between visfatin, ASP and
the incidence of childhood obesity and the significance
of them in diagnoses and therapy of children obesity.
Eighty-six children (57 boys and 29 girls) including 40
obese children,22 overweight children and 24 normal con-
trol children were recruited with ages ranged 7-15 years.
Serum visfatin and ASP levels were determined by ELISA.
(1) As compared with normal and overweight children,
serum visfatin level was significantly higher in obese chil-
dren (p<0.05); As compared with normal children
(p<0.01) and overweight children (p<0.05), serum ASP
level was significantly higher in obese children. There
were no differences of serum visfatin and ASP levels
between normal and overweight children. (2) The body
mass index, TC, TG, LDL-c, FPG, FINS, insulin resis-
tance index of the obese children were higher than the
normal children (p<0.05 or p<0.01); the HDL-c and insu-
lin sensitivity index of the obese children were lower
than the normal group (p<0.01 or p<0.05). The body
mass index, the fasting insulin, insulin resistance index of
the obese children were higher than the overweight chil-
dren (p<0.01). (3) Correlation Analysis: Serum visfatin
and body mass index and TG were positively correlated
(respectively r = 0.218, p<0.05; r = 0.500, p<0.01). ASP
and body mass index, total cholesterol, triglycerides were
positively correlated (respectively r = 0.268, p<0.05; r =
0.250, p <0.05; r = 0.427, p<0.01).
In simple obesity children, there were a significant
change in serum visfatin and ASP, and visfatin and ASP
involved in the disorder of lipids metabolism in obese chil-
dren. Serum visfatin and ASP levels can be used as a new
indicator to evaluate the risk of childhood obesity trends
and future valuation of diabetes, cardiovascular.
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